A group of clinicians and informaticians reviewed 21 eMERGE phenotype algorithms (Table 2) and several authoring tools (Measure Authoring Tool [www.emeasuretool.cms.gov], i2b2, Eureka!, PhenotypePortal, the Vanderbilt Synthetic Derivative,27 (link) and the Marshfield Personalized Medicine Research Project interface58 ) for common features. These phenotyping algorithms were of different complexity and included both disease and drug response phenotypes using algorithms from the eMERGE22 (link) and Pharmacogenomics of Very Large Populations (PGPop) networks. We also evaluated the ability to represent selected well-known diagnostic criteria (e.g., Duke criteria for infective endocarditis,52 (link) CHADS2 criteria for anticoagulation therapy in atrial fibrillation (AF)51 (link)) as potential phenotypes (see Supplementary Appendix Part 2). After proposal by a smaller team of investigators, the desiderata were evaluated and refined by all authors, which included investigators from eMERGE, PGRN, PGPop, SHARPn, PCORNet, and HMO Research Network.